Coronavirus Vaccine
/ Integral Molecular
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
July 23, 2022
Broadly neutralizing antibodies target the coronavirus fusion peptide.
(PubMed, Science)
- "COV44-79 limited disease caused by SARS-CoV-2 in a Syrian hamster model. These findings highlight the fusion peptide as a candidate epitope for next-generation coronavirus vaccine development."
Journal • Infectious Disease • Novel Coronavirus Disease • Respiratory Diseases
March 23, 2020
Newly added product
(Pharmaceutical-technology.com)
- Preclinical, Novel Coronavirus Disease
Pipeline update
1 to 2
Of
2
Go to page
1